/manager/Index ${session.getAttribute("locale")} 5 Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancer /manager/Repository/uon:21390 p< 0.001) in urinary dysfunction were measured using the EORTC PR25 instrument at 18 and 36 months. Conclusion: Adjuvant androgen suppression, bisphosphonates and increasing EBRT dose did not increase rectal or urinary dysfunction in this trial. However dose escalation using HDRB increased urinary dysfunction.]]> Sat 24 Mar 2018 08:05:03 AEDT ]]> Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial /manager/Repository/uon:22823 Sat 24 Mar 2018 07:16:10 AEDT ]]>